Publication date
July 2015
DOIAbstract
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococc
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococc
Introduction Previous series on the use of daptomycin in enterococcal infective endocarditis (EIE) h...
Staphylococcus aureus, coagulase-negative staphylococci, and Enterococcus spp. represent the most fr...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Evo...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
Assessment of the place of daptomycin in the treatment of endocarditis and bacteraemia requires assi...
International audienceObjectives - Daptomycin has become a first-line therapeutic option for vancomy...
Objective: Infective endocarditis (IE) carries a high risk of cardiac morbidity and mortality, despi...
ObjectivesAmong viridans group streptococcal infective endocarditis (IE), the Streptococcus mitis gr...
Abstract Enterococci are the third most frequent cause of infective endocarditis. A high-24 inoculum...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Enterococci are the thirdmost frequent cause of infective endocarditis. A high-inoculum stationary-p...
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections inc...
The activity of daptomycin was assessed against 545 isolates of Gram-positive bacteria including ent...
The efficacy of treatment with a combination of ampicillin, imipenem, and vancomycin was compared wi...
Among the viridans group streptococci, the Streptococcus mitis group is the most common cause of inf...
Introduction Previous series on the use of daptomycin in enterococcal infective endocarditis (EIE) h...
Staphylococcus aureus, coagulase-negative staphylococci, and Enterococcus spp. represent the most fr...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Evo...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
Assessment of the place of daptomycin in the treatment of endocarditis and bacteraemia requires assi...
International audienceObjectives - Daptomycin has become a first-line therapeutic option for vancomy...
Objective: Infective endocarditis (IE) carries a high risk of cardiac morbidity and mortality, despi...
ObjectivesAmong viridans group streptococcal infective endocarditis (IE), the Streptococcus mitis gr...
Abstract Enterococci are the third most frequent cause of infective endocarditis. A high-24 inoculum...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Enterococci are the thirdmost frequent cause of infective endocarditis. A high-inoculum stationary-p...
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive infections inc...
The activity of daptomycin was assessed against 545 isolates of Gram-positive bacteria including ent...
The efficacy of treatment with a combination of ampicillin, imipenem, and vancomycin was compared wi...
Among the viridans group streptococci, the Streptococcus mitis group is the most common cause of inf...
Introduction Previous series on the use of daptomycin in enterococcal infective endocarditis (EIE) h...
Staphylococcus aureus, coagulase-negative staphylococci, and Enterococcus spp. represent the most fr...
The Author(s) 2015. This article is published with open access at Springerlink.com Introduction: Evo...
Add to ORKG